(Q78073768)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10429838%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

title

Deposition and disposition of [11C]zanamivir following administration as an intranasal spray. Evaluation with positron emission tomography (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10429838%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

positron emission tomography

1 reference

8

B Langstrom

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10429838%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

M Bergstrom

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10429838%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

L M Cass

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10429838%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

S Valind

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10429838%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

G Westerberg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10429838%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

E L Lundberg

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10429838%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

S Gray

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10429838%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

A Bye

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10429838%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

publication date

1 January 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10429838%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacokinetics

10 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10429838%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

36 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10429838%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

33-39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10429838%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00003088-199936001-00004

10 December 2019

exact match

0 references

cites work

Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections

1 reference

12 December 2020

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

1 reference

12 December 2020

Regional deposition of inhaled 11C-nicotine vapor in the human airway as visualized by positron emission tomography

1 reference

12 December 2020

Performance characteristics of an eight-ring whole body PET scanner

1 reference

12 December 2020

Nicotine deposition and body distribution from a nicotine inhaler and a cigarette studied with positron emission tomography

1 reference

12 December 2020

Rational design of potent sialidase-based inhibitors of influenza virus replication

1 reference

12 December 2020

Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers

1 reference

12 December 2020

4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro

1 reference

12 December 2020

Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza

1 reference

12 December 2020